ArticleJournal of neuromuscular diseases2024

Comparative efficacy of risdiplam and nusinersen in Type 2 and 3 spinal muscular atrophy patients: A cohort study using real-world data.

Mahmoud Reza Ashrafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.